×

[Series] Management strategies and future challenges for aortic valve disease

The management of aortic valve disease has been improved by accurate diagnosis and assessment of severity by echocardiography and advanced imaging techniques, efforts to elicit symptoms or objective markers of disease severity and progression, and consideration of optimum timing of aortic valve replacement, even in elderly patients. Prevalence of calcific aortic stenosis is growing in ageing populations. Conventional surgery remains the most appropriate option for most patients who require aortic valve replacement, but the transcatheter approach is established for high-risk patients or poor candidates for surgery.

Ethical issues with xenotransplantation clinical trials

Xenotransplantation is the transplantation of living cells, tissues or organs from one species to another, such as from animals to humans. This includes transplanting human material that has been exposed to animal material while outside the human body.

Some animal materials are already used in humans, such as pig heart valves, but these are treated so that they contain no living cells. In contrast, xenotransplants comprise living cells that perform the same functions as the organ, tissue or cells they are intended to replace.

Progress in international research has raised interest in investigating xenotransplantation as an alternative to the clinical use of human material.

While whole organ xenotransplantation remains a distant possibility until research overcomes immunological hurdles, there has been much progress in cellular xenotransplantation. The immunological, microbiological and physiological barriers to xenotransplantation are being investigated in pre-clinical and clinical trials internationally. Ultimately, these could be tested in Australian clinical trials.

Australia has a robust framework for the conduct of clinical trials, yet there is limited guidance on the ethical review and conduct of xenotransplantation trials.

Such trials pose unique challenges due to the potential for transmitting infectious and untreatable diseases from animals to humans. This poses a risk not only to research participants, but also to people with whom they come into contact.

Researchers conducting xenotransplantation may need to consider lifelong monitoring and to provide information about the trial to close contacts.

To address these issues, the Australian Health Ethics Committee of the National Health and Medical Research Council has drafted a chapter on xenotransplantation for inclusion in the National Statement on Ethical Conduct in Human Research. This chapter outlines institutional and researcher responsibilities, and highlights ethical considerations associated with xenotransplantation.

The draft chapter will soon be released for public consultation. For more information, visit http://www.nhmrc.gov.au/health-ethics/ethical-issues/animal-human-transplantation-research-xenotransplantation.

News briefs

CSIRO finds new way to harvest stem cells

Scientists at the CSIRO have found a new way to harvest stem cells which reduces the time required to obtain adequate numbers of cells, without the need for a growth factor, according to research published in Nature Communications. “Current harvesting methods take a long time and require injections of a growth factor to boost stem cell numbers. This often leads to side effects. The method … combines a newly discovered molecule (known as BOP), with an existing type of molecule (AMD3100) to mobilise the stem cells found in bone marrow out into the bloodstream. Combining the two molecules directly impacts stem cells so they can be seen in the blood stream within an hour of a single dosage.” The researchers also found that “when the harvested cells are transplanted they can replenish the entire bone marrow system, and there are no known side effects”. The next step is a Phase I clinical trial assessing the combination of BOP molecule with the growth factor, prior to the eventual successful combination of the two small molecules BOP and AMD3100. The research was done in collaboration with the Australian Regenerative Medicine Institute at Monash University.

Trial deaths spark idelalisib safety warning

The Therapeutic Drugs by Administration (TGA) is reviewing information provided the manufacturers of cancer drug idelalisib (marketed as Zydelig) after some patients died while taking the drug in clinical trials overseas, the ABC reports. “The TGA said the drug was first prescribed in 2015 to patients with rare blood cancers like chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma, who have failed other treatments. The drug works by blocking particular proteins inside cancer cells that encourage the cancer to grow. Drugmaker Gilead Sciences Inc was carrying out six clinical trials to find out whether idelalisib could be a frontline treatment, rather than a last resort for terminal patients. The company said adverse events were discovered during the trials, but would not say how many patients died or suffered serious side effects.” A spokesman for the TGA said doctors should avoid using idelalisib as a first-line treatment. “Patients starting or continuing treatment with idelalisib should be carefully monitored for signs of infections,” the TGA spokesman said. Lymphoma Australia said it was also concerned for patients using the drug. “We strongly advise anyone taking it to talk to their doctor and perhaps consider an alternative treatment,” said Lymphoma Australia’s chief executive Sharon Millman.

Zika link to microcephaly supported

New research published in The Lancet estimates that the risk of microcephaly is about “1 for every 100 women infected with the Zika virus during the first trimester of pregnancy”, based on data from the 2013–14 outbreak in French Polynesia. The outbreak began in October 2013, peaked in December 2013 and ended in April 2014. Over that period, more than 31 000 people saw their doctor with suspected Zika virus infection. Over the course of the outbreak, eight cases of microcephaly were identified. Of these, five pregnancies were terminated through medical abortion (average gestational age 30.1 weeks), and three cases were born. The authors, from the French Institut Pasteur, said that the risk, although low, remains an important public health issue because the risk of Zika virus infection is particularly high during outbreaks, such as the current one in South America. A linked comment in the same issue said: “Further data will soon be available from Pernambuco, Colombia, Rio de Janeiro, and maybe other sites … The fast production of knowledge during this epidemic is an opportunity to observe science in the making: from formulation of new hypotheses and production of new results that will provide confirmations and contradictions to the refinement of methods and the gradual building of consensus.”

Dramatic shift on concussion findings

The National Football League, the United States’ highest-profile sports competition, has finally admitted that the game is connected to high rates of chronic traumatic encephalopathy (CTE), the degenerative brain disease found in nearly 100 of its former players, the New York Times reports. After years of denying evidence from medical experts, a senior NFL official, speaking at a round-table discussion with US policymakers, was asked if there was a link between football and degenerative brain disorders like CTE. Jeff Miller, the NFL’s senior vice president for health and safety policy, said: “The answer to that is certainly, yes.” Lawyers for some players involved in a lawsuit with the NFL over its handling of brain injuries quickly seized on the league’s admission. The NYT reports: “The NFL’s denials of any link between football brain trauma and CTE began before the first case was even identified. In a study published in the journal Neurosurgery, which examined head injuries sustained by players from 1996 through 2001, the league’s committee on concussions said that no player had developed the disease — even though CTE can be diagnosed only by examining brain tissue after death, and no deceased player had ever undergone such a procedure.”

[Perspectives] Ovarian cancer

On Christmas Day 1809, as the residents of Danville, Kentucky, sang carols in their churches, Jane Todd Crawford prepared for a terrible ordeal. 46 years old and the mother of four children, Crawford believed she was pregnant again with twins, but the full term had passed and her belly continued to swell. On Dec 13, 1809, she consulted the surgeon Ephraim McDowell, who diagnosed a massive ovarian tumour. Born in 1771, McDowell studied medicine in Virginia and Edinburgh, where he might have read John Hunter’s discussion of surgery for ovarian cancer.

[Perspectives] Radiation’s risks and cures

The earliest radiograph, a 15-min exposure taken by Wilhelm Röntgen in 1895, remains the most famous image in the history of radiation. Less well known is the frightened comment of Röntgen’s wife on viewing her skeleton: “I have seen my own death!” Possibly in reaction, a cautious Röntgen took precautions to shield himself with lead and experienced no ill effects, unlike some other experimenters. As early as 1901, physician Francis Williams called for the protection of physicians and patients in The Roentgen Rays in Medicine and Surgery: As an Aid in Diagnosis and as a Therapeutic Agent.

Male neurosurgeons highest ATO earners, GPs in top 50

With an average income of almost 577,000, male neurosurgeons have topped the list of the highest income status of Australians released by the Australian Tax Office.

Other medical specialities round out the top five for men, with Ophthalmologist, Cardiologist, Plastic and reconstructive surgeon and Gynaecologist/Obstetrician being the most lucrative jobs.

Among women, it was a slightly different story. The job with the highest income wasn’t in medicine at all, but was the role of a Judge. Neurosurgeon, plastic and reconstructive surgeon and Vascular surgeon came in at two, three and five respectively however future trader was number four in the list.

The statistics found that male specialists earned roughly twice as much as their female counterparts, however it didn’t distinguish between full and part time.

With an average income of $184,639, male general practitioners came in at 48th on the list while female GPs were 40th with an average income of $129,834.

According to the ATO, the statistics don’t include some of Australia’s top earners due to privacy protection or because their career title was unavailable.

Those with the lowest incomes, under $20,000 per year were fruit and nut pickers, deer farmer and fast food cook.

Read the full list at the ATO’s website.

Top 50 average incomes for Men and Women

  1. Neurosurgeon $577,674 Judge – law $355,844
  2. Ophthalmologist $552,947 Neurosurgeon $323,682
  3. Cardiologist $453,253 Plastic and reconstructive surgeon $281,608
  4. Plastic and reconstructive surgeon $448,530 Futures trader $281,600
  5. Gynaecologist; Obstetrician $446,507 Vascular surgeon $271,529
  6. Otorhinolaryngologist  $445,939 Gynaecologist; Obstetrician $264,628
  7. Orthopaedic surgeon $439,629 Gastroenterologist $260,925
  8. Urologist $433,792 Magistrate $260,161
  9. Vascular surgeon $417,524 Anaesthetist $243,582
  10. Gastroenterologist  $415,192 Ophthalmologist  $217,242
  11. Diagnostic and interventional radiologist  $386,003 Cardiologist $215,920
  12. Dermatologist  $383,880  Urologist $213,094
  13. Judge – law  $381,323 Surgeon – general  $210,796
  14. Anaesthetist  $370,492 Medical oncologist $208,612 
  15. Cardiothoracic surgeon  $358,043 Specialist physicians – other  $207,599
  16. Surgeon – general  $ 357,996 Specialist physician – general medicine $207,225
  17. Specialist physicians – other  $344,860 Otorhinolaryngologist $200,136
  18. Radiation oncologist $336,994 Dermatologist $195,030
  19. Medical oncologist   $322,178 Diagnostic and interventional radiologist  $180,695
  20. Securities and finance dealer $320,452 Cardiothoracic surgeon  $175,500
  21. Thoracic medicine specialist  $315,444 Paediatric surgeon  $175,314
  22. Specialist physician – general medicine $315,114 Endocrinologist $174,542
  23. Intensive care specialist $308,033 Member of parliament  $173,331
  24. Renal medicine specialist $298,681  Rheumatologist $169,409
  25. Neurologist   $298,543 Intensive care specialist $169,369
  26. Financial investment manager $288,790 Emergency medicine specialist $165,786
  27. Investment broker  $286,530 Orthopaedic surgeon $159,479
  28. Paediatric surgeon  $282,508 Neurologist $155,217
  29. Clinical haematologist $271,738 Renal medicine specialist $155,133
  30. Futures trader  $264,830 Psychiatrist $152,437
  31. Endocrinologist  $258,972 Clinical haematologist $147,970
  32. Cricketer  $257,527 Paediatrician $147,347
  33. Rheumatologist $256,933 Securities and finance dealer $145,208
  34. Dental specialist $253,442 Dental specialist $140,505
  35. Magistrate $246,737 Actuary $136,819
  36. Equities analyst; Investment dealer $245,826 Radiation oncologist $135,678
  37. Paediatrician $239,405 Financial investment manager $134,481
  38. Stock exchange dealer Stockbroker $238,192  Petroleum engineer $133,315
  39. Psychiatrist  $234,557  Mining production manager $133,061
  40. Emergency medicine specialist $232,595  General medical practitioner $129,834
  41. Member of parliament $232,093   Thoracic medicine specialist $127,645
  42. Pathologist $224,378 Stockbroker $124,433
  43. Company secretary – corporate governance $218,432 Paving plant operator $123,281
  44. State governor  $212,652 Mining engineer $119,564
  45. Actuary  $196,144 Tribunal member $119,219
  46. Doctor – medical practitioner – other; Occupational medicine specialist; Public health physician; Sports physician $187,468 Doctor – medical practitioner – other; Occupational medicine specialist; Public health physician; Sports physician  $118,310
  47. Petroleum engineer $185,808  Geophysicist $117,575
  48. General medical practitioner $184,639  Chief executive officer; Executive director; Managing director; Public servant – secretary or deputy secretary $116,855
  49. Chief executive officer; Executive director; Managing director; Public servant – secretary or deputy secretary  $181,849  Engineering manager $116,732
  50. Mining production manager  $179,439 Metallurgist $110,359

Latest news:

Rural health – the continuing challenge

Rural health is frequently inferior to city health. This old generalisation covers much contradictory detail, and exceptions abound: according to the Australian Institute of Health and Welfare, the life expectancy of non-Indigenous women in 2002-04 was much the same – 84 – whether they lived in big cities or very remote areas.  For men, the difference is a matter of six months or so. And it is not a rigid generalisation: increasingly sophisticated broadband-enabled communications and ever-more efficient transport have reduced the gap between city and country. 

Nevertheless, the numbers and the facts suggest that the accumulation of wealth, talent and many other features of contemporary city life confer a small advantage in life expectancy and wellbeing on city-dwellers. This disparity challenges those who hold the value that one of our social duties is to ensure, as far as possible, equality of opportunity to health and health care to all Australians. What should we do?

Two pathways to action present themselves for our consideration.

The first, and the one most easily grasped by the medical profession, concerns access to medical care in the rural setting. Massive technologically-based services can only be provided in large cities, and lesser technology-dependent services need at least strong regional bases.

We are getting better at finding ways to make these technologies available in relation to services such as radiotherapy, relieving the pressure on country women to favour radical breast surgery because they cannot afford the time and separation for chemo and radiotherapy.

But as we concentrate on providing rapid care for people with acute coronary syndrome and stroke (an increasing possibility in cities), the challenge of providing similar care in remote parts of the country may be beyond us at present.

The attitude of some to this problem – that those who live in remote parts of the country do so entirely by choice – is similar to saying that drowning people should be left, as they chose to swim or go boating.

But with telehealth, and many large city medical services increasingly interested in providing networked services to places that lack them, the problem is being partially addressed.

The search for equality of access may well require affirmative funding, and this has been recognised to some extent in fee structures and remuneration.

Equality does not mean paying the same for the care of people in different places: we need to accept that services provided beyond cities will cost more, and ensure that we finance them accordingly.

There are also concerns, raised most recently by Max Kamien, Emeritus Professor of General Practice at the University of Western Australia in Medical Observer, that the relaxation of hiring rules in many rural areas will “open the floodgates” to corporate practices.

While on the surface of it, a boost to the number of doctors working in rural areas would be welcome, this is not the case if they are being employed on short-term contracts to simply churn through large numbers of patients, and leave more challenging and time-consuming cases to existing practices. The focus needs to be on quality of care, not just quantity.

The extent to which the learned colleges have recognised the need for greater action on behalf of their rural members has been variable.

A framework for rural health developed by representatives of all Australian states, territories and the Commonwealth in 2011, recognised the need to be sensitive to the special needs of older people, babies and children, Aboriginal and Torres Strait Islander people, people with chronic disease, refugees and people from culturally and linguistically diverse backgrounds.

The second approach to rural health disparities takes us well beyond the surgery.

Even with networked services, e-health, and affirmative funding, we are faced with residual differences in health status that are attributable to the social and economic context of rural and remote life.

Medicine cannot, for example, diminish the vast distances many country people have to drive, every kilometre increasing their risk of a serious accident. At best, it can be sensitive to distance when arranging care of patients with continuing problems.

Medicine cannot do much to promote high-quality educational opportunity, although the development of regional universities and technical education capacity has been impressive in the past three decades.

Rural clinical schools have done a remarkable job in acquainting future medical practitioners and other health professionals with the challenges and opportunities of rural practice, and the long-term effects of this intervention will be seen in the next 20 years.

Medicine, though, has no influence over agricultural and extractive industry policies, all of which have great significance for employment and economic sustainability in rural communities.

These environmental factors – the social determinants of health – set the health agenda.

Some fall within the sphere of influence of public health, but many are well beyond even its wide reach.

Their importance was reviewed in a paper by Jane Dixon, from the ANU, and Nicky Welch, from Waikato University, in The Australian Journal of Rural Health in 2000. ‘What is it about rural places or the rural experience that contributes to different health outcomes?’ they ask.

The broad-spectrum advocacy of the Rural Doctors Association of Australia and the Rural Health Alliance contribute to the wider political and policy agenda that may help us to answer this question and to make serious progress.

It is vital for medicine to respond to the needs of rural communities as they are, not as they might be in a reimagined ideal world.

My sense is that we are making steady progress.  The indicators that we have favour an optimistic view.

Patients pay for hobbled hospitals

Since the Commonwealth’s unilateral changes to public hospital funding announced in the 2014-15 Budget, the AMA has highlighted the impact of dramatically reduced funding on an already underperforming public hospital system.

In May 2014, the Australian Government walked away from the National health Reform Agreement, abandoning its promise to make public hospital funding sustainable and contribute an equal share towards growth in public hospital costs.

From July 2017, the Commonwealth will instead limit its contribution to public hospital costs based on a formula of the Consumer Price Index (CPI) and population growth only. This represents the lowest Commonwealth contribution to public hospital funding since the Second World War.

According to Treasury, the indexation change will reduce Commonwealth funding to the states and territories by $57 billion between 2017-18 to 2024-25.

The CPI measures changes in prices faced by households only, and is not an appropriate measure of increases in hospital costs. Increasing funding on the basis of population growth does not address cost increases associated with changing demographics, or the costs of new health technologies.

The Finance and Economics Committee resolved last year that the Commonwealth’s contribution to public hospital funding must be sufficient to address real increases in actual costs of the goods and services used by hospitals, and provide for demographic change – not only for population growth, but also for changes associated with ageing and health needs.

The Government’s ongoing justification for its extreme health savings measures, including cuts to public hospital funding, has been that Australia’s health spending is unsustainable.

This is simply not substantiated by the evidence.

The Government’s own figures show that health spending grew by 3.1 per cent in 2013-14. This is almost 2 percentage points lower than the average growth over the last decade (5 per cent). The previous year (2012-13) growth was even slower – just 1.1 per cent, which was the lowest annual increase since Government began reporting on health spending in the mid-1980s.

Clearly, total health spending is not out of control. The health sector is doing more than its share to ensure health expenditure is sustainable.

There have now been two years where growth in health expenditure has been well below the long-term average annual growth of 5 per cent over the last decade.

As part of this slowdown, growth in Commonwealth funding for public hospitals in 2013-14 was just 0.9 per cent, well below inflation and virtually stagnant. This is off the back of a 2.2 per cent reduction in Commonwealth funding of public hospitals in 2012-13.

This austerity has come at a cost, and has been reflected in the performance of our public hospitals. The AMA’s Public Hospital Report Card 2016 shows that, against key measures, the performance of our public hospitals is virtually stagnant or, in many cases, declining. This is the direct effect on patient care of reduced growth in hospital funding and capacity.

The most recent data shows waiting times are largely static, with only very minor improvement. Emergency Department (ED) waiting times have worsened. The percentage of ED patients treated in four hours has not changed, and is well below target. Elective surgery waiting times and treatment targets are largely unchanged. Bed number ratios have also deteriorated.

The Commonwealth’s funding cuts are already having a real impact as a result of almost $2 billion being sliced from programs to reduce emergency department and elective surgery waiting times.

But the most acute impact will be felt from July next year, when the new funding arrangements take effect.

Without sufficient funding to increase capacity, public hospitals will never meet the performance targets set by governments, and patients will wait longer for treatment, putting lives at risk.

Despite these warnings, we have yet to see a solution to the serious and rapidly approaching crisis in public hospital funding.

This is a crisis that has been created by political and budgetary decisions. It is one that will require political leadership to resolve.

 

– Brian Owler

 

Shine a light on murky insurance deals: AMA

Health insurance premiums are being inflated by commissions and many consumers are being lured into unnecessarily switching cover because of murky arrangements between health funds and insurance comparison websites, the AMA has warned.

Releasing its inaugural Private Health Insurance Report Card, the nation’s peak medical organisation has urged greater Government scrutiny of health insurance industry practices which is says may be distorting the market and undermining the value of private health insurance cover.

As consumer anger over looming premium price hikes builds, the AMA has developed the Report Card to help consumers understand how the market operates and enable them to make better informed choices regarding their health cover.

Launching the Report Card, AMA President Professor Brian Owler said it was common for patients coming to hospital for surgery shocked to discover they were not covered, forcing them to cancel or defer treatment or facing unexpected out-of-pocket costs.

“The AMA wants every person who has private health insurance to know what their policy covers them for, and to review it every year to make sure it continues to meet their needs,” Professor Owler said.

The Report Card addresses two of the biggest gripes of policyholders – gaps and shortcomings in cover, and out-of-pocket fees.

It sets out the level of cover each of the nation’s 35 insurers provides and it details differences in the benefits paid by eight funds for 22 common procedures, including birth, hip and knee replacement, cataract surgery, coronary bypass, vasectomy, haemorrhoid treatment and breast biopsy.

The AMA said there were four main levels of cover, from top private hospital through to public hospital-only policies that President Owler said were junk and should be banned.

He said often policies had misleading names that implied they would provide a much higher level of cover than they actually did, creating the risk that consumers would be caught out when they were most in need.

“There are a lot of policies on offer that provide public hospital-only cover. These are better known as ‘junk’ policies, because they do not support patient choice of doctor or timing for health services or procedures,” Professor Owler said. “It is the AMA’s view that junk policies should be banned outright.”

Even where a treatment is covered by insurance, patients may still be left with out-of-pocket expenses if the benefit paid by the insurer falls short.

For privately insured patients, Medicare pays 75 per cent of the MBS fee, and health funds 25 per cent or more. The bulk of services are provided by doctors with no gap, when Medicare and the health fund between them cover the full total cost of treatment. Sometimes, there is a ‘known gap’, where practitioners charge a fee a set amount above the benefit.

But the Report Card shows that the benefits paid by insurers vary considerably, and the AMA “strongly recommends” that patients seek an estimate from their doctor, including the cost of any implant, and then talk with their insurer prior to treatment.

The AMA has released its Report Card amid concerns that premium increases set to come into effect from 1 April will spur thousands to consider downgrading their cover.

Earlier this month, Health Minster Sussan Ley claimed a victory of sorts after convincing 20 of the nation’s 35 private health funds to lower planned premium increases, a move she said had saved consumers $125 million.

But the average 5.59 per cent increase is virtually treble the inflation rate, and is expected to feed consumer dissatisfaction with the value of private health insurance.

Professor Owler said it was important that consumers were fully informed and aware about the consequences of taking out cheaper cover, which would usually entail more restrictions and exclusions, as well as higher excess.

He said it was particularly worrying that people looking to hold their premium costs down would be duped into taking out junk policies.

“If people have one of the junk policies, the AMA urges them to consider carefully what cover they really need,” the AMA President said.

In addition to the quality of cover on offer, the AMA has raised concerns about the operations of websites that compare health insurance policies.

Professor Owler said these ‘free’ comparator sites earned often exorbitant commissions from insurers, either a fixed percentage of a premium or a fixed fee per sale, which could act as an incentive to get consumers to switch policies.

Either way, the fees could make up a sizeable proportion of the total insurance premium, he said, urging a greater level of transparency and Government scrutiny.

The Australian Competition and Consumer Commission last year issued a report highly critical of the quality and accuracy of information provided by the health funds.

Echoing AMA concerns, the watchdog warned that comparator websites often included only a selection of insurers or policies on offer, and added “they may have commercial relationships with, or receive financial inducements from, listed businesses”.

Ms Ley has launched a review into the private health insurance industry to examine regulation of the sector, including the setting of premiums, as well as other issues including the industry’s push into primary health care; a possible relaxation of community rating principles; and a proposal to replace health insurance rebates with Medicare-style payments for hospital care.

Adrian Rollins

 

 

AMA in the News

Your AMA has been active on policy and in the media on a range of issues crucial to making our health system better. Below is a snapshot of recent media coverage.

Print/Online

Focus on health wins, Northern Territory News, 20 February 2015

AMA President Professor Brian Owler visited health facilities in Alice Springs, as well as the Indigenous communities of Utopia, Ampilatwatja, and Kintore. Professor Owler said Indigenous health gains might be slow, but it is important successes are not lost in a sea of depressing statistics.

Angry medicos urge action over plight of detainees, Sydney Morning Herald, 22 February 2016

AMA President Professor Brian Owler has savaged the Department of Immigration and Border Protection for what he says has been its intimidation of doctors who speak out about the plight of asylum seekers.

Row stymies e-health rollout, AFR Weekend, 27 February 2016

Pharmacists and doctors are feuding over the Federal Government’s struggling electronic My Health Record system. AMA President Professor Brian Owler said the organisation backed e-health records as a way of controlling health costs, but the Government had failed to ask medical specialists what they needed to make My Health Record work.

Hangover cure no miracle as clinic closes, Sun Herald, 28 February 2016

NSW health authorities have launched an investigation into a national chain of hydration clinics after a Sydney woman was hospitalised following an intravenous vitamin infusion sold as a miracle hangover cure. AMA Vice President Dr Stephen Parnis has accused those behind the IV infusion trend of bringing the medical profession into disrepute.

Patients to feel pain as cuts bite, Adelaide Advertiser, 11 March 2016

Across Australia, public hospitals will lose more than a $1 billion in federal funding next year. AMA President Professor Brian Owler said as hospital capacity shrinks, doctors won’t be able to get their patients into hospital or keep them there to receive the critical care they require.

AMA warns of hospital funding crisis as cuts bite, Sydney Morning Herald, 11 March 2016

Hospitals are limiting surgery hours and forcing patients to wait longer for elective procedures as an economic disaster looms. AMA president Brian Owler said patients with life-threatening conditions such as cancer would wait longer for surgery, while emergency departments would struggle to treat half their sickest patients within 30 minutes.

Porn turning kids into predators, The Australian, 29 February 2016

Online pornography is turning children into copycat sexual predators, doctors and child abuse experts warned. AMA Vice President Dr Stephen Parnis said the internet was exposing children to sexually explicit content that taught sex was about use and abuse.

Radio

Professor Brian Owler, Radio National, 22 February 2016

AMA President Professor Brian Owler discussed calling for the immediate removal of infants and children from immigration detention centres, and for all asylum seekers to have access to quality health care.

Dr Stephen Parnis, 2HD Newcastle, 22 February 2016

AMA Vice President Dr Stephen Parnis discussed Turnbull Government plans for asylum seeker Baby Asha and her family to be returned to Nauru once medical and legal process are complete. Dr Parnis said doctors were in an untenable situation in treating patients with serious physical and mental health issues, particularly the children, who were under threat of return to conditions that will only exacerbate their health problems.

Dr Stephen Parnis, 5AA Adelaide, 28 February 2016

AMA Vice President Dr Stephen Parnis talked about hangover clinics. He said clinics which claim to cure hangovers through intravenous infusions have no benefit and could put lives at risk.

Professor Brian Owler, 2UE Sydney, 11 March 2015

AMA President Professor Brian Owler talked about public hospital funding. Professor Owler said Australia has one of the best health care systems in the world, but it relies on having adequate funding. 

Television

Professor Brian Owler, ABC Melbourne, 21 February 2016

Federal Immigration Minister, Peter Dutton, says that asylum seeker baby Asha and her family will moved to community detention, and not immediately sent to Nauru. The AMA reiterated its call for all children to be immediately released from detention

Dr Stephen Parnis, ABC Melbourne, 2 February 2016

A new report warns that Australia isn’t properly prepared for health problems triggered by an increase in heat waves over the next 40 years. AMA Vice President Dr Stephen Parnis said hundreds of people could die every year if nothing is done to tackle climate change.

Dr Stephen Parnis, Channel 10, 8 March 2015

An official submission to the Government proposes increasing the tax on alcohol. AMA Vice President Dr Stephen Parnis is supportive of increasing the price.

Professor Brian Owler, Prime 7, 10 March 2016

AMA President Professor Brian Owler warns regional communities they will be worst hit when the Federal Government’s hospital cuts take effect from next year. AMA urges the Government to prioritise health when it lays down the budget in May.

Professor Brian Owler, Sky News, 10 March 2016

AMA President Professor Brian Owler talks about the No Jab, No Pay laws coming into force on March 18, when parents who don’t ensure their child’s immunisation is up-to-date stand to lose childcare benefits.